• How has acellular therapy evolved over the years? • What are the strategies and methods of implementation in the acellular therapy industry which can affect the future perception of the market? • ...

Please provide your email address to receive an email when new articles are posted on . The acellular implant group had statistically significant improvements in overall outcome scores and subscores.

Between July 1997 and April 1998, all provinces and territories in Canada switched from using a combination vaccine of diphtheria and tetanus toxoids, whole-cell pertussis, inactivated poliovirus and ...

Acellular pertussis vaccines protected against disease but did not prevent infection and transmission, whereas whole-cell vaccines were more effective, according to findings from a primate model study ...

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global acellular dermal matrices market is estimated to be valued at US$ 6,483.6 million in 2020 and is expected to exhibit a CAGR ...

DURHAM, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissues at ...

Please provide your email address to receive an email when new articles are posted on . Symvess is a sterile, cell-free tissue engineered vessel made of human extracellular matrix proteins. Among 54 ...

Background: The transition from a whole-cell to a 5-component acellular pertussis vaccine provided a unique opportunity to compare the effect that each type of vaccine had on the incidence of ...

In a trial, an acellular tissue engineered vessel had superior functional patency for hemodialysis with acceptable safety compared with an arteriovenous fistula in high-risk patients. An acellular ...

Impact of a novel inflammation-based prognostic system on patients undergoing surgery for colorectal cancer: A retrospective study of 480 Japanese patients. This is an ASCO Meeting Abstract from the ...

ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of ...